Membership Crown
    Introducing FrontFundr Elite Circle:
    Sign-up today to receive bonus shares and reduced fees on investments
    FrontFundr
    Investors
    • Opportunities
    • Why Invest
    • Elite Circle
    Businesses
    • Why Raise
    • Community Raise
    • EMD Processing
    • Case Studies
    • Get Investor Ready
    Resources
    • Help Center
    • Blog
    • Podcast
    • Publications
    Company
    • About Us
    • Press & Media
    • Contact Us
    FrontFundr

    Making early-stage investing accessible to all Canadians.

    • instagram
    • facebook
    • linkedin
    • spotify
    • youtube
    DisclosurePrivacy PolicyTerms of Use
    pcmanaco

    © Copyright 2026 FrontFundr Financial Services Inc. (FFS).  All rights reserved. FrontFundr Financial Services Inc. (FFS), doing business as FrontFundr and SMV Capital Markets, is registered as an exempt market dealer in BC, AB, SK, MB, ON, QC, NB, NS, NL, PE & YT. Investing in crowdfunding and exempt market offerings has significant risk. Investors may not be able to resell quickly or at all. An exempt market security holder may also receive limited ongoing issuer information. You should invest only if you are prepared not to receive any return on your investment and/or lose your investment in its entirety.

    For Investors

    • Opportunities
    • Why Invest
    • Investor Membership

    For Businesses

    • Why Raise
    • Community Raise
    • EMD Processing
    • Funded Companies
    • Refer a Business
    • Case Studies
    • Get Investor Ready

    Company

    • About Us
    • Blog
    • Podcasts
    • Publications
    • Press & Media
    • Contact
    Starpax Biopharma Update
    Share
    Copied!
    Sep 25
    2024
    An innovative cancer treatment for solid tumours

    A Canadian Cancer Society-awarded project has discovered an innovative cancer therapy using bacteria and magnetism which is being further developed by a Montreal-based company.


    Although chemotherapy drugs are successful in treating certain cancers, they can cause uncomfortable side effects and are not very efficient at reaching all cancer cells in a tumour. But a new scientific breakthrough that uses a specialized treatment platform that distributes anti-cancer drugs throughout the inside of tumours, is hoping to change that. This innovative concept was first devised by Dr Sylvain Martel at Polytechnique Montréal and the technology is now being developed into a new method for cancer therapy by Starpax Biopharma.


    To read the complete article: An innovative cancer treatment for solid tumours | Canadian Cancer Society

    Andréanne Cyr
    Vice President Finance & Administration